Melodiol Global Health facing creditor and loan debts of $17m, report reveals by Steve Jones December 19, 2024December 19, 2024 Troubled Melodiol Global Health has racked up A$17 million worth of debt, an initial administrator’s report […]
Health House for sale as parent company remains suspended from ASX by Steve Jones September 12, 2024September 12, 2024
Melodiol ‘evaluating proposal’ to sell ‘various core assets’ by Steve Jones January 17, 2024July 11, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
Canopy duo back together at Creso but ‘with a new sheriff in town’ by Steve Jones March 24, 2022April 29, 2024
